Public-private partnerships in drug development for underdeveloped countries: An interview with Craig Wheeler, president of chiron's biopharmaceutical division

被引:0
|
作者
Kushner, T
机构
关键词
D O I
10.1017/S0963180103124127
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:429 / 433
页数:5
相关论文
共 24 条
  • [21] Mainstreaming sustainable development goals in Ghana's energy sector within the framework of public-private partnerships: challenges, opportunities and strategies
    Owusu-Manu, De-Graft
    Adjei, Thomas Kankam
    Sackey, David Mensah
    Edwards, David John
    Hosseini, Reza M.
    JOURNAL OF ENGINEERING DESIGN AND TECHNOLOGY, 2021, 19 (03) : 605 - 624
  • [22] The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships
    Bresee, Joseph S.
    Lafond, Kathryn E.
    McCarron, Margaret
    Azziz-Baumgartner, Eduardo
    Chu, Susan Y.
    Ebama, Malembe
    Hinman, Alan R.
    Xeuatvongsa, Anonh
    Bino, Silvia
    Richardson, Dominique
    Porter, Rachael M.
    Moen, Ann
    McKinlay, Mark
    VACCINE, 2019, 37 (35) : 5089 - 5095
  • [23] The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance
    Kostyanev, T.
    Bonten, M. J. M.
    O'Brien, S.
    Steel, H.
    Ross, S.
    Francois, B.
    Tacconelli, E.
    Winterhalter, M.
    Stavenger, R. A.
    Karlen, A.
    Harbarth, S.
    Hackett, J.
    Jafri, H. S.
    Vuong, C.
    MacGowan, A.
    Witschi, A.
    Angyalosi, G.
    Elborn, J. S.
    dewinter, R.
    Goossens, H.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (02) : 290 - 295
  • [24] Expanding Public-Private Collaborations to Enhance Cancer Drug Development: A Report of the Institute of Medicine's Workshop Series, "Implementing a National Cancer Clinical Trials System for the 21st Century"
    Bertagnolli, Monica M.
    Canetta, Renzo
    Nass, Sharyl J.
    ONCOLOGIST, 2014, 19 (11): : 1179 - 1185